Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening and confirmation tests for SARS-CoV-2: benefits and drawbacks

11 Jan 2023

Abstract excerpt

Background: Coronavirus disease 2019 is a pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection that emerged in late 2019 and has activated an ongoing international public health emergency. SARS-CoV-2 was discovered in Wuhan, China, in December 2019 and rapidly spread to other cities and countries. Currently, SARS-CoV-2 diagnostic tests have relied heavily on detecting viral...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to SARS-CoV-2 detection and testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36647397
DOI: 10.1186/s43088-023-00342-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening and confirmation tests for SARS-CoV-2: benefits and drawbacksPMID 36647397Read ↗

Current Trends of SARS-CoV-2 and its New Variants Diagnostics in Different Body Fluids: Surface Antigen, Antibody, Nucleic Acid, and RNA Sequencing Detection TechniquesSemantic proximity Read ↗

A comparative review of immunoassays for COVID-19 detectionSemantic proximity Read ↗

Advanced Molecular and Immunological Diagnostic Methods to Detect SARS-CoV-2 InfectionSemantic proximity Read ↗

Analytical evaluation and critical appraisal of early commercial SARS-CoV-2 immunoassays for routine use in a diagnostic laboratorySemantic proximity Read ↗

A Method to evaluate analytical sensitivity of qRT-PCR kits for SARS-CoV-2 detectionSemantic proximity Read ↗

Evaluating ten commercially-available SARS-CoV-2 rapid serological tests using the STARD (Standards for Reporting of Diagnostic Accuracy Studies) methodSemantic proximity Read ↗

True or false: what are the factors that influence COVID-19 diagnosis by RT-qPCR?Semantic proximity Read ↗

Assessment of Real-Time RT-PCR Kits for SARS-CoV-2 DetectionSemantic proximity Read ↗

Recent biotechnological tools for diagnosis of corona virus disease: A reviewSemantic proximity Read ↗

An acceptable method to evaluate the analytical performance of real-time fluorescent RT-PCR targeting SARS-CoV-2Semantic proximity Read ↗

Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy studySemantic proximity Read ↗

Rapid implementation of SARS-CoV-2 emergency use authorization RT-PCR testing and experience at an academic medical institutionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.